示例按钮
HOME
ABOUT
TECHNOLOGY
R & D
Pipeline
rhTSH
Molecular Nuclear Imaging
PD-L1 Expression
TIL Distribution
NEWS
CONTACT
中文
NEWS
Close
Back
CORPORATE NEWS
+ 查看更多
SmartNuclide Biopharma Announces First Patient Treated in Phase 1/2 Clinical Trial of SNA001 for Well-Differentiated Thyroid Cancer
2019/02/12
SmartNuclide’s SNA001 Receives NMPA’s First Investigational New Drug Approval for Recombinant Human TSH
2018/10/18
Innovative Radiopharmaceutical Company SmartNuclide Closes Series Pre-A Financing
2018/03/07
COPYRIGHT © 2019 SMARTNUCLIDE
